Astatine-211: One Alpha, No Loose Daughters

Radiopharmacy · 3 min read

Astatine-211 is the halogen alpha emitter. It delivers exactly one alpha particle per decay, by either of its two routes, and leaves behind no free alpha-emitting daughter — the problem that limits actinium-225. Its own limitation is chemical rather than physical.

At a glance

The decay

• 41.8% — direct alpha to ²⁰⁷Bi.
• 58.2% — electron capture to ²¹¹Po, which alpha-decays in ~0.5 s to stable ²⁰⁷Pb.
• ²⁰⁷Bi is long-lived, about 32 years, but decays by electron capture — not by alpha.
• ²¹¹Po emits polonium K X-rays at 77–92 keV. They are imageable on a gamma camera, so the therapy can be counted and quantified.

Why one alpha matters

• ²²⁵Ac delivers four alphas down a chain. Its recoiling daughters escape the chelate and redistribute — the origin of its salivary and renal toxicity.
• ²¹¹At leaves no free alpha-emitting daughter. The dose stays where the molecule went.
• The cost is time: 7.2 hours against 9.9 days. It suits fast-targeting vectors, not slow ones.
• Production has a ceiling as well as a target. Above roughly 29 MeV the (α,3n) channel opens and makes ²¹⁰At, whose daughter ²¹⁰Po is severely radiotoxic — which is why the beam energy is specified rather than maximised.

The weakness is chemical

• A halogen, attached by astatination much as iodine is by iodination.
• The carbon–astatine bond is weaker than carbon–iodine, and breaks in vivo.
• Released astatide is handled by the sodium-iodide symporter, like iodide: thyroid, stomach, salivary glands.
• The same fact cuts both ways — it is why ²¹¹At has also been explored as an alpha alternative to ¹³¹I.
• Mitigated by more stable carriers such as closo-decaborate cages, and by blocking agents.

Clinical use

All early-phase

The pattern: compartmental or microscopic disease, where a 50–70 µm range is the point rather than a limitation.

The other multi-purpose element: Terbium, the Swiss Army knife.